Urate oxidase: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
The enzyme '''urate oxidase''' ('''UO'''), or '''uricase''' or '''factor-independent urate hydroxylase''', absent in humans, catalyzes the [[oxidation]] of [[uric acid]] to [[5-hydroxyisourate]]:<ref name="PUB00002471">{{cite journal |author=Motojima K, Goto S, Kanaya S |title=Cloning and sequence analysis of cDNA for rat liver uricase |journal=J. Biol. Chem. |volume=263 |issue=32 |pages=16677–16681 |year=1988 |pmid=3182808}}</ref> | The enzyme '''urate oxidase''' ('''UO'''), or '''uricase''' or '''factor-independent urate hydroxylase''', absent in humans, catalyzes the [[oxidation]] of [[uric acid]] to [[5-hydroxyisourate]]:<ref name="PUB00002471">{{cite journal |author=Motojima K, Goto S, Kanaya S |title=Cloning and sequence analysis of cDNA for rat liver uricase |journal=J. Biol. Chem. |volume=263 |issue=32 |pages=16677–16681 |year=1988 |pmid=3182808}}</ref> | ||
Revision as of 17:51, 13 April 2015
|
WikiDoc Resources for Urate oxidase |
|
Articles |
|---|
|
Most recent articles on Urate oxidase Most cited articles on Urate oxidase |
|
Media |
|
Powerpoint slides on Urate oxidase |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Urate oxidase at Clinical Trials.gov Trial results on Urate oxidase Clinical Trials on Urate oxidase at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Urate oxidase NICE Guidance on Urate oxidase
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Urate oxidase Discussion groups on Urate oxidase Patient Handouts on Urate oxidase Directions to Hospitals Treating Urate oxidase Risk calculators and risk factors for Urate oxidase
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Urate oxidase |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The enzyme urate oxidase (UO), or uricase or factor-independent urate hydroxylase, absent in humans, catalyzes the oxidation of uric acid to 5-hydroxyisourate:[1]
- Uric acid + O2 + H2O → 5-hydroxyisourate + H2O2 → allantoin + CO2
 |
 |
 |
Structure
Urate oxidase is mainly localised in the liver, where it forms a large electron-dense paracrystalline core in many peroxisomes.[2] The enzyme exists as a tetramer of identical subunits, each containing a possible type 2 copper-binding site.[3]
Urate oxidase is a homotetrameric enzyme containing four identical active sites situated at the interfaces between its four subunits. UO from A. flavus is made up of 301 residues and has a molecular weight of 33438 dalton. It is unique among the oxidases in that it does not require a metal atom or an organic co-factor for catalysis. Sequence analysis of several organisms has determined that there are 24 amino acids which are conserved, and of these, 15 are involved with the active site.
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significance of absence in humans
Humans do have a gene for urate oxidase, but it is nonfunctional. Thus uric acid is the end product of catabolism of purines in humans. Excessive concentration of uric acid in the blood stream leads to gout.
Urate oxidase is found in nearly all organisms, from bacteria to mammals, and plays different metabolic roles, depending on its host organism. It was lost in early primate evolution,[3] and so is absent in humans and other higher apes.
It has been proposed that the loss of urate oxidase protein expression has been advantageous to hominids, since uric acid is a powerful antioxidant and scavenger of singlet oxygen and radicals.[4] Its presence provides the body with protection from oxidative damage, thus prolonging life and decreasing age-specific cancer rates. However, this is highly unlikely as proteins are capable of being activated only when concentrations exceed a certain amount. Adequate uric acid levels could still be maintained to protect the body while preventing evolutionarily disadvantageous conditions like gout.[dubious ]
Urate oxidase is formulated as a protein drug (rasburicase) for the treatment of acute hyperuricemia in patients receiving chemotherapy. A PEGylated form of urate oxidase is in clinical development for treatment of chronic hyperuricemia in patients with "treatment-failure gout".
In legumes
UO is also an essential enzyme in the ureide pathway, where nitrogen fixation occurs in the root nodules of legumes. The fixed nitrogen is converted to metabolites that are transported from the roots throughout the plant to provide the needed nitrogen for amino acid biosynthesis.
In legumes, 2 forms of uricase are found: in the roots, the tetrameric form; and, in the uninfected cells of root nodules, a monomeric form, which plays an important role in nitrogen-fixation.[5]
References
- ↑ Motojima K, Goto S, Kanaya S (1988). "Cloning and sequence analysis of cDNA for rat liver uricase". J. Biol. Chem. 263 (32): 16677–16681. PMID 3182808.
- ↑ Motojima K, Goto S (1990). "Organization of rat uricase chromosomal gene differs greatly from that of the corresponding plant gene". FEBS Lett. 264 (1): 156–158. doi:10.1016/0014-5793(90)80789-L. PMID 2338140.
- ↑ 3.0 3.1 Lee CC, Caskey CT, Wu XW, Muzny DM (1989). "Urate oxidase: primary structure and evolutionary implications". Proc. Natl. Acad. Sci. U.S.A. 86 (23): 9412–9416. doi:10.1073/pnas.86.23.9412. PMC 298506. PMID 2594778.
- ↑ Ames BN, Cathcart R, Schwiers E, Hochstein P (November 1981). "Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis". Proc. Natl. Acad. Sci. U.S.A. 78 (11): 6858–62. doi:10.1073/pnas.78.11.6858. PMC 349151. PMID 6947260.
- ↑ Nguyen T, Zelechowska M, Foster V, Bergmann H, Verma DPS (1985). "Primary structure of the soybean nodulin-35 gene encoding uricase II localized in the peroxisomes of uninfected cells of nodules". Proc. Natl. Acad. Sci. U.S.A. 82 (15): 5040–5044. doi:10.1073/pnas.82.15.5040. PMC 390494. PMID 16593585.